SYNLOGIC, INC. Stock Repurchase Program, Number of Shares Authorized to be Repurchased
SYNLOGIC, INC. (SYBX) had Stock Repurchase Program, Number of Shares Authorized to be Repurchased of 1.22 million shares as of 2017-09-30, per its 10-Q filed 2017-11-13.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased · last filed 2017-11-13
- 2017-09-30: Stock Repurchase Program, Number of Shares Authorized to be Repurchased 1.22M shares.
| Period end | Stock Repurchase Program, Number of Shares Authorized to be Repurchased |
|---|---|
| 2017-09-30 | 1.22M shares 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |